Ambulatory Surgery Centers (ASC)

Global Ambulatory Surgery Centers (ASC) Market to Reach US$143.9 Billion by 2030

The global market for Ambulatory Surgery Centers (ASC) estimated at US$100.3 Billion in the year 2024, is expected to reach US$143.9 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Gastroenterology, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$47.0 Billion by the end of the analysis period. Growth in the Ophthalmology segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.9 Billion While China is Forecast to Grow at 9.7% CAGR

The Ambulatory Surgery Centers (ASC) market in the U.S. is estimated at US$25.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$34.2 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Ambulatory Surgery Centers (ASC) Market - Key Trends and Drivers Summarized

Why Are Ambulatory Surgery Centers Becoming the Preferred Choice for Outpatient Surgeries?

Ambulatory Surgery Centers (ASCs) have rapidly gained prominence as a preferred option for outpatient surgeries, fundamentally transforming how surgical care is delivered. ASCs are specialized medical facilities designed to perform surgical procedures that do not require overnight hospitalization, offering a more streamlined and patient-focused approach compared to traditional hospital settings. One of the key drivers of their popularity is the efficiency they provide, with patients often experiencing shorter wait times, more convenient scheduling, and faster recovery, as they can typically return home on the same day as their procedure. ASCs cater to a wide array of specialties, including orthopedics, gastroenterology, ophthalmology, and pain management, and advancements in medical technology have allowed more complex surgeries, such as knee replacements and cataract surgeries, to be performed safely in these outpatient environments. The focus on specialized, outpatient care results in lower overhead costs, making ASCs a more cost-effective solution for both patients and healthcare providers. Additionally, the rise of value-based care, which emphasizes quality outcomes and patient satisfaction over the volume of procedures, has aligned perfectly with the ASC model, as these centers focus on delivering high-quality care in a more efficient, patient-friendly setting.

What Sets Ambulatory Surgery Centers Apart from Hospital-Based Surgeries?

Ambulatory Surgery Centers offer distinct advantages over traditional hospital settings, making them highly attractive to patients and insurers alike. A major differentiator is the cost-effectiveness of ASCs. On average, surgeries performed in ASCs are 30-50% less expensive than the same procedures in hospitals, primarily due to lower facility fees and reduced administrative costs. This cost reduction is beneficial not only for patients but also for insurers and government healthcare programs like Medicare, which have increasingly directed patients to ASCs for elective surgeries. Beyond cost savings, ASCs offer a more specialized and focused environment for surgical procedures. With a narrower scope of services compared to hospitals, ASCs are able to optimize their workflows, resulting in fewer delays, shorter procedure times, and quicker discharge. This efficiency benefits both patients, who spend less time waiting and recovering, and surgeons, who can maintain more control over their surgical schedules. The risk of hospital-acquired infections (HAIs), a major concern in larger, inpatient settings, is also significantly lower in ASCs, making them an appealing choice for patients seeking elective surgeries. Additionally, many ASCs are physician-owned, which fosters a sense of accountability and allows surgeons to have more control over the surgical environment, leading to higher patient satisfaction and improved outcomes.

How Are Technological Advancements and Patient Preferences Shaping the Future of ASCs?

Technological innovations and evolving patient preferences are driving significant changes in the way Ambulatory Surgery Centers operate and grow. The development of minimally invasive surgical techniques, such as laparoscopic and robotic-assisted surgeries, has allowed ASCs to perform increasingly complex procedures while minimizing recovery times. These technologies reduce the physical trauma associated with surgery, allowing patients to return home the same day and recover more quickly in the comfort of their own homes. Moreover, advances in anesthesia techniques have made outpatient surgeries safer and more comfortable, with fewer side effects and less need for prolonged post-operative monitoring. The rise of digital health and telemedicine is also transforming how ASCs interact with patients. Virtual pre-operative consultations, online scheduling, and remote post-operative follow-ups have made the entire surgical process more efficient and accessible, enhancing the patient experience. These tools allow patients to engage more actively in their care, which is becoming increasingly important as healthcare consumerism grows. Patients today prioritize convenience, transparency, and control over their healthcare choices, and ASCs—offering shorter waiting times, personalized care, and lower costs—align well with these expectations. As a result, ASCs are becoming the preferred option for elective surgeries, where patients seek high-quality care without the complexities and costs associated with hospitals.

What Factors Are Driving the Growth of Ambulatory Surgery Centers?

The growth of Ambulatory Surgery Centers is driven by several key factors that reflect broader changes in healthcare delivery and patient expectations. One of the primary drivers is the shift toward cost-effective care, as both insurers and patients seek more affordable alternatives to hospital-based surgeries. The lower operational costs of ASCs, coupled with their ability to deliver high-quality care, make them a financially attractive option. Insurers, including Medicare, have increasingly incentivized the use of ASCs for outpatient surgeries, further fueling their growth. Another significant driver is the aging population, which has led to an increased demand for surgeries, particularly in orthopedics and cardiovascular care, both of which are well-suited for outpatient settings. As surgical technologies and anesthesia techniques have advanced, more procedures can be performed safely in ASCs, expanding their role in the healthcare system. Regulatory changes have also played a pivotal role in the expansion of ASCs. For example, Medicare’s decision to approve a broader range of procedures for coverage in ASCs has made these centers more accessible to older patients, leading to increased demand. The rise of value-based care, which emphasizes patient outcomes and cost efficiency, has further driven the adoption of ASCs, as they are able to deliver quality care at lower costs while minimizing the need for hospital admissions. Additionally, as patients become more involved in their healthcare decisions, they are choosing ASCs for their convenience, shorter recovery times, and personalized care experiences. Urbanization and the decentralization of healthcare are also contributing to the growth of ASCs, with new centers being established in both urban and suburban areas to meet the increasing demand for outpatient surgical services. All these factors are converging to position ASCs as a critical component of the future healthcare system, offering patients a more accessible, cost-effective, and patient-centered alternative to traditional hospital-based care.

SCOPE OF STUDY:

The report analyzes the Ambulatory Surgery Centers (ASC) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Application (Gastroenterology, Ophthalmology, Orthopedics, Pain Management / Spinal Injections, Plastic Surgery, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Community Health Systems, Inc.
• Edward-Elmhurst Health
• Envision Healthcare Corporation
• Group Eifelhöhen-Klinik AG
• Healthway Medical Group
• MEDNAX Services, Inc
• NOVENA GLOBAL HEALTHCARE GROUP, INC.
• Prospect Medical Group
• Quorum Health Corporation
• SurgCenter Development

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs CBob geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.